Skip to main content
. 2021 Apr 9;14:101058. doi: 10.1016/j.bonr.2021.101058

Fig. 6.

Fig. 6

Na[18F]F PET-CT of case 2 before denosumab treatment (left, anterior and posterior view) and after 1.5 years of therapy (right, anterior and posterior view). Visually, the intensity appears similar at the second scan, mainly due to overprojection. Nevertheless a decrease in SUVpeak by 11% was measured, in SUVmean by 16%, FTV by 13% and TLF by 27%.